LENZILUMAB
UNII IE4X6497XK

Substance Identification & Data

This profile provides standardized clinical and technical data for Lenzilumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) IE4X6497XK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1229575-09-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

IE4X6497XK

CAS Registry Number

1229575-09-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LENZILUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C125081

National Cancer Institute reference terminology for clinical and research data.

INN ID

9965

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-127

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lenzilumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LENZILUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CSF2 (COLONY STIMULATING FACTOR 2 (GRANULOCYTE-MACROPHAGE), GRANULOCYTEMACROPHAGE COLONY STIMULATING FACTOR, GM-CSF)), HOMO SAPIENS MONOCLONAL ANTIBODY

LENZILUMAB [INN]

LENZILUMAB [USAN]

LENZILUMAB [WHO-DD]